The lancet. Psychiatry最新文献

筛选
英文 中文
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. 临床稳定的精神分裂症谱系障碍患者继续、减少、切换或停用抗精神病药物:系统回顾和网络荟萃分析
The lancet. Psychiatry Pub Date : 2022-08-01 Epub Date: 2022-06-23 DOI: 10.1016/S2215-0366(22)00158-4
Giovanni Ostuzzi, Giovanni Vita, Federico Bertolini, Federico Tedeschi, Beatrice De Luca, Chiara Gastaldon, Michela Nosé, Davide Papola, Marianna Purgato, Cinzia Del Giovane, Christoph U Correll, Corrado Barbui
{"title":"Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.","authors":"Giovanni Ostuzzi, Giovanni Vita, Federico Bertolini, Federico Tedeschi, Beatrice De Luca, Chiara Gastaldon, Michela Nosé, Davide Papola, Marianna Purgato, Cinzia Del Giovane, Christoph U Correll, Corrado Barbui","doi":"10.1016/S2215-0366(22)00158-4","DOIUrl":"10.1016/S2215-0366(22)00158-4","url":null,"abstract":"<p><strong>Background: </strong>Although antipsychotic maintenance treatment is widely recommended to prevent relapse in chronic psychoses, evidence-based guidelines do not provide clear indications on different maintenance treatment strategies, including continuing the antipsychotic at standard doses, reducing the dose, switching to another antipsychotic, or even stopping the antipsychotic. We aimed to compare the effectiveness of these maintenance treatment strategies, hypothesising the superiority of all strategies over stopping, and of continuing at standard doses over both switching and reducing the dose.</p><p><strong>Methods: </strong>We did a systematic review and network meta-analysis of randomized controlled trials (RCTs) that investigated antipsychotics for relapse prevention in adults with schizophrenia-spectrum disorders who were clinically stable, and which compared four treatment strategies: continuing the current antipsychotic at standard doses recommended for acute treatment; reducing the current antipsychotic dose; switching to a different antipsychotic; and stopping the antipsychotic and replacing it with placebo. We excluded RCTs with fewer than 25 individuals, a prerandomisation washout period greater than 4 weeks, a follow-up shorter than 6 weeks, and those recruiting treatment-resistant individuals. We searched MEDLINE, EMBASE, PsycINFO, CINAHL, CENTRAL, and online trial registers for published and unpublished RCTs from inception to Sept 1, 2021, combining terms describing all available antipsychotics, and terms describing continuation, maintenance, or long-term treatment for schizophrenia-spectrum disorders. Relative risks (RRs) and standardised mean differences were pooled using random-effects pairwise and network meta-analyses. We assessed risk of bias of each RCT with the Cochrane Risk-of-Bias 2 tool, and confidence of pooled estimates with CINeMA. The primary outcome was relapse prevention. The study protocol was registered in advance in the Open Science Forum registry.</p><p><strong>Findings: </strong>Of 3936 records identified, 119 records, reporting on 101 RCTs, were eligible, 98 of which (including 13 988 individuals) provided data that could be meta-analysed for at least one outcome. The mean proportion of female participants per study was 38% (range 0-100; median 39%, IQR 29-50), whereas for male participants it was 62% (range 0-100; median 61%, IQR 50-71), and the overall mean age was 38·8 years (range 23·2-63·9; median 39·3, IQR 35·0-43·9). Of the 98 RCTs meta-analysed, 89·8% were done in high-income and upper-middle-income countries. The ethnic group White or so-called Caucasian was the most represented (mean 56% participants per study), although this information was relatively scarce. All continuation strategies were significantly more effective in preventing relapse than stopping antipsychotic treatment, with a large risk reduction for continuing at standard doses (RR 0·37, 95% CI 0·32-0·43; number-needed-to","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"614-624"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40399438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antipsychotic maintenance treatment versus dose reduction: how the story continues. 抗精神病药物维持治疗与减少剂量:故事如何继续。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 Epub Date: 2022-06-23 DOI: 10.1016/S2215-0366(22)00230-9
Iris E C Sommer, Mark Horowitz, Kelly Allott, Helene Speyer, Marieke J H Begemann
{"title":"Antipsychotic maintenance treatment versus dose reduction: how the story continues.","authors":"Iris E C Sommer,&nbsp;Mark Horowitz,&nbsp;Kelly Allott,&nbsp;Helene Speyer,&nbsp;Marieke J H Begemann","doi":"10.1016/S2215-0366(22)00230-9","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00230-9","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"602-603"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40399439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Policy changes needed to address the mental health impact of COVID-19 in Iran. 应对2019冠状病毒病对伊朗心理健康影响所需的政策变化。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 DOI: 10.1016/S2215-0366(22)00203-6
Leila Doshmangir, Kamal Gholipour, Vladimir Sergeevich Gordeev
{"title":"Policy changes needed to address the mental health impact of COVID-19 in Iran.","authors":"Leila Doshmangir,&nbsp;Kamal Gholipour,&nbsp;Vladimir Sergeevich Gordeev","doi":"10.1016/S2215-0366(22)00203-6","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00203-6","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"e35"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
USA. 美国。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 DOI: 10.1016/S2215-0366(22)00240-1
Yochai Re'em
{"title":"USA.","authors":"Yochai Re'em","doi":"10.1016/S2215-0366(22)00240-1","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00240-1","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"611"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cultivating collaboration in mania. 在躁狂中培养合作。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 DOI: 10.1016/S2215-0366(22)00229-2
Bart Lutters
{"title":"Cultivating collaboration in mania.","authors":"Bart Lutters","doi":"10.1016/S2215-0366(22)00229-2","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00229-2","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"e36"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive home treatment in different settings. 在不同环境下进行强化家庭治疗。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 Epub Date: 2022-06-30 DOI: 10.1016/S2215-0366(22)00199-7
Claire Henderson
{"title":"Intensive home treatment in different settings.","authors":"Claire Henderson","doi":"10.1016/S2215-0366(22)00199-7","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00199-7","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"603-604"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40472708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression in Indians 45 years and older: a roadblock in healthy ageing. 45岁及以上印度人的抑郁症:健康老龄化的障碍。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 DOI: 10.1016/S2215-0366(22)00233-4
Rahul Shidhaye
{"title":"Depression in Indians 45 years and older: a roadblock in healthy ageing.","authors":"Rahul Shidhaye","doi":"10.1016/S2215-0366(22)00233-4","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00233-4","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"605-606"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paola Dazzan: exploring without fear. 保拉·迪赞:无所畏惧地探索。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 DOI: 10.1016/S2215-0366(22)00239-5
Priya Venkatesan
{"title":"Paola Dazzan: exploring without fear.","authors":"Priya Venkatesan","doi":"10.1016/S2215-0366(22)00239-5","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00239-5","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"610"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40511095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating HIV and substance misuse services: a person-centred approach grounded in human rights. 整合艾滋病毒和药物滥用服务:以人权为基础的以人为本的办法。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-08-01 Epub Date: 2022-06-21 DOI: 10.1016/S2215-0366(22)00159-6
Victoria Haldane, Anne-Sophie Jung, Chuan De Foo, Pami Shrestha, Elena Urdaneta, Eva Turk, Juan I Gaviria, Jesus Boadas, Kent Buse, J Jaime Miranda, Steffanie A Strathdee, Ashley Barratt, Michel Kazatchkine, Martin McKee, Helena Legido-Quigley
{"title":"Integrating HIV and substance misuse services: a person-centred approach grounded in human rights.","authors":"Victoria Haldane,&nbsp;Anne-Sophie Jung,&nbsp;Chuan De Foo,&nbsp;Pami Shrestha,&nbsp;Elena Urdaneta,&nbsp;Eva Turk,&nbsp;Juan I Gaviria,&nbsp;Jesus Boadas,&nbsp;Kent Buse,&nbsp;J Jaime Miranda,&nbsp;Steffanie A Strathdee,&nbsp;Ashley Barratt,&nbsp;Michel Kazatchkine,&nbsp;Martin McKee,&nbsp;Helena Legido-Quigley","doi":"10.1016/S2215-0366(22)00159-6","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00159-6","url":null,"abstract":"<p><p>Integrating HIV-related care with treatment for substance use disorder provides an opportunity to better meet the needs of people living with these conditions. People with substance use disorder are rendered especially vulnerable by prevailing policies, structural inequalities, and stigmatisation. In this Series paper we analyse existing literature and empirical evidence from scoping reviews on integration designs for the treatment of HIV and substance use disorder, to understand barriers to and facilitators of care integration and to map ways forward. We discuss how approaches to integration address two core gaps in current models: a failure to consider human rights when incorporating the perspectives of people living with HIV and people who use drugs, and a failure to reflect critically on structural factors that determine risk, vulnerability, health-care seeking, and health equity. We argue that successful integration requires a person-centred approach, which is grounded in human rights, treats both concerns holistically, and reconnects with underlying social, economic, and political inequalities.</p>","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"676-688"},"PeriodicalIF":64.3,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40397444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Pathways to depressive and anxiety disorders during and after the COVID-19 pandemic. 在COVID-19大流行期间和之后,抑郁症和焦虑症的途径。
IF 64.3
The lancet. Psychiatry Pub Date : 2022-07-01 DOI: 10.1016/S2215-0366(22)00152-3
J C Lokman, C L Bockting
{"title":"Pathways to depressive and anxiety disorders during and after the COVID-19 pandemic.","authors":"J C Lokman,&nbsp;C L Bockting","doi":"10.1016/S2215-0366(22)00152-3","DOIUrl":"https://doi.org/10.1016/S2215-0366(22)00152-3","url":null,"abstract":"","PeriodicalId":240194,"journal":{"name":"The lancet. Psychiatry","volume":" ","pages":"531-533"},"PeriodicalIF":64.3,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39991528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信